NCT00480116View on ClinicalTrials.gov

Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Adjuvanted Hepatitis B vaccine Lot 1

20 µg, IM, month 0 and 1

BIOLOGICAL

Adjuvanted Hepatitis B vaccine Lot 2

20µg, IM, month 0 and 1

BIOLOGICAL

Adjuvanted Hep B vaccine Lot 3

20µg, IM, month 0 and 1

Trial Locations (1)

500 03

Vaccination and Travel Medicine Centre Poliklinika II, Hradec Králové

Sponsors

Lead Sponsor

Henogen
All Listed Sponsors
lead

Henogen

INDUSTRY

NCT00480116 - Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule | Biotech Hunter | Biotech Hunter